세계의 알레르기 진단 및 치료 시장

The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.

The North American market for allergy diagnostics and treatment is projected to grow from $39.7 billion in 2025 to $56.7 billion by the end of 2030, at a CAGR of 7.4% from 2025 through 2030.

The Asia-Pacific market for allergy diagnostics and treatment is projected to grow from $8.6 billion in 2025 to $12.9 billion by the end of 2030, at a CAGR of 8.6% from 2025 through 2030.

Report Scope

This report will provide detailed information on allergy diagnostics and treatments. It analyzes the market trends, with the base year for the study being 2024. It provides estimates for 2025, and forecasts for 2025 through 2030, including the compound annual growth rate (CAGR) for the forecast period. It also analyzes regional markets. This report will highlight allergy diagnostics, current and future market potential of treatments, and a detailed competitive environment analysis. The report will cover regulatory scenarios, drivers, restraints, and opportunities. Also included will be market shares for key players.

The market is segmented into two major categories: diagnostics and treatments. Diagnostics include skin testing (prick, patch, intradermal) and blood testing (antibody). Treatments include antihistamines, sympathomimetics, decongestants and combinations, corticosteroids, leukotrienes, mast cell stabilizers, immunotherapy, and others. Immunotherapy is further segmented into subcutaneous administration, sublingual liquid solutions, and sublingual tablets. The treatments market is segmented into food, drug, inhaled, and others based on allergen type. Drug types are market segmented into prescription drug and over-the-counter (OTC).

The allergy diagnostics and treatment market has been segmented into North America, Europe, the Asia-Pacific, the Middle East and Africa (MEA), and South America. The detailed regional analysis will cover major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data will be provided with 2024 as the base year.

Report Includes

• 161 data tables and 54 additional tables
• Analyses of the trends in global markets for allergy diagnostics, immunotherapy and treatments, with revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
• Estimates of the size and revenue prospects for the global market, along with a market share analysis by type, diagnostic type, treatment type, allergen type, drug type, route of administration, and region
• Facts and figures pertaining to the market dynamics, new developments in diagnostic testing, advances in treatments, new regulations, and the impact of macroeconomic factors
• Insights derived from the Porter's Five Forces model, as well as global supply chain analyses
• Evaluation of recent patent activity and key granted and published patents
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading biotech companies
• Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity, venture fundings and investment outlook
• Profiles of leading companies, including ALK-Abello A/S, Stallergenes Greer, GSK plc., AbbVie Inc., and AstraZeneca

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Macroeconomic Factor Analysis
• Increasing Healthcare Expenditure
• Environmental Pollution and Climate Change
• Economic Development and Urbanization
• Porter's Five Forces Analysis in the Allergy Diagnostics and Treatment Market
• Threat of New Entrants (Moderate)
• Bargaining Power of Suppliers (Moderate)
• Bargaining Power of Buyers (High)
• Threat of Substitutes (High)
• Industry Rivalry (High)

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Advances in Allergy Diagnostics and Treatment
• Increasing Cases of Allergies Worldwide
• Market Restraints
• Lack of Skilled Physicians
• Side-effects of Allergy Medications
• Market Opportunities
• Robust Pipeline of Allergy Medications
• Personalized Allergy Management via Advanced Biomarker Profiling

Chapter 4 Regulatory Landscape

• Overview
• Regulatory Framework
• U.S.
• Europe
• Germany
• Japan

Chapter 5 Emerging Technologies

• Overview
• AI-driven Allergy Testing
• Datasets Management in Molecular Allergy
• Pipeline Analysis
• Patent Analysis
• Key Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Global Allergy Diagnostics and Treatment Market, by Type
• Key Takeaways
• Diagnostics
• Treatments
• Global Allergy Diagnostics and Treatment Market, by Allergen Type
• Key Takeaways
• Food Allergens
• Inhaled Allergens
• Drug Allergens
• Other Allergens
• Global Allergy Diagnostics and Treatment Market, by Drug Type
• Key Takeaways
• Prescription Drugs
• Over-the-Counter Drugs
• Market for Drugs, by Route of Administration
• Geographic Breakdown
• Global Allergy Diagnostics and Treatment Market, by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa (MEA)
• South America

Chapter 7 Competitive Intelligence

• Key Takeaways
• Company Analysis of the Allergy Diagnostics and Treatment Market
• Recent Developments
• Recent Product Launches

Chapter 8 Sustainability in the Allergy Diagnostics and Treatment Market: ESG Perspective

• Introduction to ESG
• Role of ESG in the Allergy Diagnostics and Treatment Market
• ESG Risk Ratings
• Conclusion

Chapter 9 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBVIE INC.
• ALK
• AMGEN INC.
• ASTRAZENECA
• BAYER AG
• F. HOFFMANN-LA ROCHE LTD.
• GSK PLC.
• LILLY
• NOVARTIS AG
• PFIZER INC.
• REVVITY
• SANOFI
• STALLERGENES GREER
• THERMO FISHER SCIENTIFIC INC.
• VIATRIS INC.
• Emerging Start-ups/Market Disruptors